Skip to main content
Notice2026-18441

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 10, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 174 (Thursday, September 10, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 174 (Thursday, September 10, 2026)]
[Notices]
[Pages 57620-57621]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Cancer Biomarker Development, Assay Validation, 
and Translational Technologies.
    Date: October 13, 2026.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-0395, 
<a href="/cdn-cgi/l/email-protection#e48c8597858aca978d80808d95918da48a8d8cca838b92"><span class="__cf_email__" data-cfemail="2c444d5f4d42025f454848455d59456c424544024b435a">[email&#160;protected]</span></a>.

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Drug and Biologic Therapeutic Delivery 
Study Section.
    Date: October 13-14, 2026.
    Time: 9:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Janice Duy, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-3139, 
<a href="/cdn-cgi/l/email-protection#e68c87888f8583c882939fa6888f8ec8818990"><span class="__cf_email__" data-cfemail="88e2e9e6e1ebeda6ecfdf1c8e6e1e0a6efe7fe">[email&#160;protected]</span></a>.

    Name of Committee: Applied Immunology and Disease Control 
Integrated Review Group; Interspecies Microbial Interactions and 
Infections Study Section.
    Date: October 13-14, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Irene Ramos Lopez, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4891, 
<a href="/cdn-cgi/l/email-protection#f9908b9c979cd78b9894968a9596899c83b9979091d79e968f"><span class="__cf_email__" data-cfemail="4c253e292229623e2d21233f20233c29360c222524622b233a">[email&#160;protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; Pathogenic Eukaryotes Study Section.
    Date: October 13-14, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jennifer Chien Villa, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-5436, 
<a href="/cdn-cgi/l/email-protection#157f707b7b7c7370673b637c797974557b7c7d3b727a63"><span class="__cf_email__" data-cfemail="771d1219191e11120559011e1b1b1637191e1f59101801">[email&#160;protected]</span></a>.

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Basic Mechanisms of Cancer Health Disparities Study 
Section.
    Date: October 13, 2026.
    Time: 10:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Wing-Hang Tong, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (302) 402-0360, 
<a href="/cdn-cgi/l/email-protection#d9adb6b7beae99b4b8b0b5f7b7b0b1f7beb6af"><span class="__cf_email__" data-cfemail="1c6873727b6b5c717d757032727574327b736a">[email&#160;protected]</span></a>.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Lung Immunology and Infection Study 
Section.
    Date: October 14-15, 2026.
    Time: 9:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Rupali Das, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-0023, 
<a href="/cdn-cgi/l/email-protection#0577707564696c2b616476456b6c6d2b626a73"><span class="__cf_email__" data-cfemail="0a787f7a6b6663246e6b794a646362246d657c">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Cancer Center Support Grant.
    Date: October 14-15, 2026.
    Time: 10:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 809 C, Bethesda, MD 20892, (301) 451-0359, 
<a href="/cdn-cgi/l/email-protection#e9849c828c9a81c7829c84889bdaa9878081c78e869f"><span class="__cf_email__" data-cfemail="0c617967697f64226779616d7e3f4c626564226b637a">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


[[Page 57621]]


    Dated: September 4, 2026.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2026-18441 Filed 9-9-26; 8:45 am]
BILLING CODE 4167-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on September 10, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.